PharmaShots | Incisive News in 3 Shots

Subscribe Now

Biomarker-Driven Therapy

Pfizer Reports the US FDA's Acceptance of Xalkori's (crizotinib) sNDA for Pediatric Patients with R/R Systemic ALCL

Pfizer Reports the US FDA's Acceptance of Xalkori's (crizotinib) sNDA for Pediatric Patients with R/R Systemic ALCL

September 23, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us